Catherine Cochez, advanced practice nurse at Hôpitaux Universitaires de Strasbourg, presents an introduction to the management of immune-related adverse events with immune checkpoint inhibitor therapy.
This includes an overview of the mechanism of action of ICIs, and examples, frequency and monitoring strategies for dermatological, gastrointestinal, endocrine, cardiac, pulmonary, hepatic, renal and neurological events.
This presentation is a supporting resource for the Classroom to Clinic module “Managing irAEs associated with PD-1/PDL-1 inhibitors”.
Classroom to Clinic is a complete group learning package that allows you to build tailored CME-accredited meetings in minutes, and confidently deliver an effective meeting specific to the needs of your learners. To explore Classroom to Clinic resources and more accredited CME, please visit Oncology Knowledge into Practice.
This independent educational activity is supported by an educational grant from Merck Sharp & Dohme Corp. The educational content has been developed by Liberum IME and validated by an independent steering committee; Merck Sharp & Dohme Corp has had no influence on the content of this education.